{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroControls\u2122 FD Linearity Tumor Markers II",
        "Audit\u00ae MicroControls\u2122M Linearity FD Tumor Markers II"
    ],
    "Submitter Information": "Aalto Scientific Ltd.",
    "510(k) Number": "K143573",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082717"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "December 12, 2014",
    "Summary Letter Received Date": "December 17, 2014",
    "Submission Date": "January 16, 2014",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alpha fetoprotein (AFP)",
        "Carcinoembryonic antigen (CEA)",
        "Prostate-specific antigen-total (PSA)",
        "CA-125",
        "CA19-9",
        "CA27-29",
        "free-PSA (fPSA)",
        "CA15-3"
    ],
    "Specimen Type(s)": [
        "Human serum",
        "Bovine serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Siemens Advia Centaur",
        "Abbott Architect i1000SR"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroControls\u2122 FD Linearity Tumor Markers II assayed QC material for chemistry analytes simulating human samples for linearity/calibration verification.",
    "Indications for Use Summary": "In vitro diagnostic assayed quality control material intended to simulate human patient samples for use in determining linearity, calibration verification, and verification of reportable range for specified tumor marker analytes.",
    "fda_folder": "Clinical Chemistry"
}